E-LIB Suche - Ergebnisse für: Yardley, Denise A.

1

HER2 heterogeneity and treatment response–associated profil..:

Li, Zheqi ; Metzger Filho, Otto ; Viale, Giuseppe...
Journal of Clinical Investigation. 134 (2024) 7 - p. , 2024

Link: https://doi.org/10.1172/..

2

Supplemental Figure 1 from Intrinsic Subtype and Overall Su..:

Aleix Prat ; Nadia Solovieff ; Fabrice André...
doi:10.1158/1078-0432.25232392.v1. , 2024

Link: https://doi.org/10.1158/..

3

Supplemental Table 1 from Intrinsic Subtype and Overall Sur..:

Aleix Prat ; Nadia Solovieff ; Fabrice André...
doi:10.1158/1078-0432.25232389.v1. , 2024

Link: https://doi.org/10.1158/..

4

Supplemental Table 3 from Intrinsic Subtype and Overall Sur..:

Aleix Prat ; Nadia Solovieff ; Fabrice André...
doi:10.1158/1078-0432.25232383.v1. , 2024

Link: https://doi.org/10.1158/..

5

Supplemental Table 2 from Intrinsic Subtype and Overall Sur..:

Aleix Prat ; Nadia Solovieff ; Fabrice André...
doi:10.1158/1078-0432.25232386.v1. , 2024

Link: https://doi.org/10.1158/..

6

Neoadjuvant palbociclib plus either giredestrant or anastro..:

Hurvitz, Sara A ; Bardia, Aditya ; Quiroga, Vanesa...
The Lancet Oncology. 24 (2023) 9 - p. 1029-1041 , 2023

Link: https://doi.org/10.1016/..

7

Rationale and trial design of NATALEE: a Phase III trial of..:

Slamon, Dennis J. ; Fasching, Peter A. ; Hurvitz, Sara...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

8

Intrinsic Subtype and Overall Survival of Patients with Adv..:

Prat, Aleix ; Solovieff, Nadia ; André, Fabrice...
Clinical Cancer Research. 30 (2023) 4 - p. 793-802 , 2023

Link: https://doi.org/10.1158/..

9

Matching-adjusted indirect comparison of PFS and OS compari..:

Jhaveri, Komal ; O'Shaughnessy, Joyce ; Fasching, Peter A....
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

10

Rationale and trial design of NATALEE: a Phase III trial of..:

Slamon, Dennis J ; Fasching, Peter A ; Hurvitz, Sara...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/23241. , 2023

Link: https://opus4.kobv.de/op..

11

Margetuximab Versus Trastuzumab in Patients With Previously..:

Rugo, Hope S ; Im, Seock-Ah ; Cardoso, Fatima...
qt5xf6t2rt. , 2023

Link: https://escholarship.org..

12

Rationale and trial design of NATALEE: a Phase III trial of..:

Slamon, Dennis J ; Fasching, Peter A ; Hurvitz, Sara...
Therapeutic Advances in Medical Oncology, Vol.15, pp.1-16. , 2023

Link: https://hdl.handle.net/1..

13

Margetuximab Versus Trastuzumab in Patients With Previously..:

Rugo, Hope S ; Im, Seock-Ah ; Cardoso, Fatima...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839304/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Matching-adjusted indirect comparison of PFS and OS compari..:

Komal Jhaveri ; Joyce O'Shaughnessy ; Peter A. Fasching...
https://doi.org/10.1177/17588359231216095. , 2023

Link: https://doi.org/10.1177/..

15

Observational Evidence of S-web Source of the Slow Solar Wi..:

Baker, Deborah ; Démoulin, Pascal ; Yardley, Stephanie L...
info:eu-repo/semantics/altIdentifier/doi/10.3847/1538-4357/acc653. , 2023

Link: https://hdl.handle.net/2..